Fate Therapeutics Layoffs
January 2023
Fate Therapeutics announced a layoff affecting 315 employees (57% of its workforce) in January 2023. The company operates in the Healthcare sector.
315
57%
Jan 9, 2023
About
Fate Therapeutics, a clinical-stage biopharmaceutical company based in San Diego, is laying off 315 employees, representing more than half of its workforce. This reduction will leave the company with 220 employees after the first quarter of 2023. The layoffs, which affect all departments including senior leadership and R&D, are part of a major restructuring following the termination of a key collaboration agreement with Janssen Biotech. The company is also discontinuing several natural killer cell programs to focus its pipeline on multiple myeloma and CAR T-cell therapies for solid tumors. Despite the cuts, Fate Therapeutics reports sufficient cash reserves to sustain operations through 2025.
More Healthcare Layoffs
Report an Error
If you find incorrect information, please let us know so we can correct it.
support@layoffs.nl